Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cholesterol in Myelin: Supply Routes, Pathological Consequences, Biophysical Governance, and Future Frontiers.
Cerebellitis and cytotoxic lesions of the corpus callosum after COVID-19 infection.
MicroRNA profiles in multiple sclerosis: A review of the literature.
How are interleukin-6 receptor antagonists shaping the future of neuromyelitis optica spectrum disorder?
VEP Abnormalities in Treatment-Naïve CIS/Early RRMS Without Prior Optic Neuritis: Clinical, Radiological, and CSF Associations.
Long-Term Outcome of Aquaporin 4-Positive Neuro Myelitis Optica Spectrum Disorder and Efficacy of Long-Term Immunosuppression - A Single-Center Study from South India.
Evaluation of the DTI-ALPS index in neuromyelitis optica spectrum disorder: a cross-sectional study of its correlation with disease duration and disability.
Associations between Paramagnetic Rim Lesions and Gadolinium Contrast Permeability of Perivascular Spaces in Patients with Multiple Sclerosis: A T1 mapping study.
Renal Disease in ROSAH Syndrome Masquerading as Lupus Nephritis: A Case Report and Cohort Analysis.
Diabetic Peripheral Neuropathy: Mechanisms and Emerging Therapies.
Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathology.
Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort.
Combined internal neurolysis and targeted proximal trigeminal root glycerol delivery for refractory multiple sclerosis-related trigeminal neuralgia: a case report.
Dental-amalgam exposure and the risk and progression of multiple sclerosis.
Peripheral Neuropathy Induced by a Short Course of Metronidazole: A Case Report of Diagnostic Challenge.
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.
Complexities in evaluation and management of infectious myelopathies.
Intrathecal IgM species as potential prognostic biomarkers in relapsing-remitting multiple sclerosis.
A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death.
Early Human Intrathecal Mesenchymal Stem Cell Study in Progressive Multiple Sclerosis Faces Delivery Challenges.
The evolution of criteria for assessing disease activity and progression in multiple sclerosis (or the "saga of acronyms").
Multiple Sclerosis and Outpatient Physician Care in the Last Years of Life: A Population-Based Study.
Long-term follow-up of patients with multiple sclerosis over age 60: Comparing clinical and radiological outcomes in disease-modifying therapy continuers and discontinuers.
Corrigendum to "Clinical and cognitive outcomes in Ocrelizumab-treated MS patients: Insights into the wearing-off phenomenon" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106689].
Intrathecal baclofen pump failure due to pain-induced autonomic dysreflexia.

Pages